Europe out of step with the US.
Alcorn
K
K
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000600:supply & distribution / Q000627:therapeutic use; D016527:Drug Costs; D005060:Europe; D017320:HIV Protease Inhibitors / Q000600:supply & distribution / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000600:supply & distribution / Q000627:therapeutic use; D019259:Lamivudine; D011804:Quinolines / Q000600:supply & distribution / Q000627:therapeutic use; D019438:Ritonavir; D019258:Saquinavir; D013844:Thiazoles / Q000600:supply & distribution / Q000627:therapeutic use; D014481:United States; D014633:Valine / Q000600:supply & distribution / Q000627:therapeutic use; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use; D015215:Zidovudine / Q000600:supply & distribution / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D013844:Thiazoles; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D014633:Valine; D016049:Didanosine; D019258:Saquinavir; D019438:Ritonavir